chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mild vertigo; Chills; low grade fever; Then 2 days of headache; This is a spontaneous report from a contactable consumer (patient herself). A 45-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: ER8735), via an unspecified route of administration, administered in Arm Left on 25Apr2021 15:15 (Age at Vaccination was 45years) as dose 2, single for COVID-19 immunisation at Pharmacy or Drug Store. The patient medical history was none. The patient concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 04Apr2021 15:15 (Age at Vaccination was 45years) as dose 1, single for COVID-19 immunisation and experienced Sore arm, pain on arm lead to unable to sleep and Vertigo. Patient did not received any other vaccine in four weeks and did not receive any other medications in two weeks prior COVID vaccination. She was not diagnosed with COVID prior vaccination and not tested with COVID post vaccination. She has no Known allergies. On 25Apr2021 18:00, the patient experienced mild vertigo, chills, low grade fever for 1 day, then 2 days of headache. The patient underwent lab tests and procedures which included fever: low on 25Apr2021. No therapeutic measures were taken as a result of events. The outcome of the events were recovered with sequelae (Recovered with lasting effects) on 2021.  No follow-up attempts are required. No further information is expected.
Patient, otherwise healthy his whole life. We noticed that sometime shortly after his vaccination, Patients pallor and demeanor changed. He was pale, dark circles under his eyes, lethargic. We noticed that he was constantly thirsty and then he started getting up multiple times a night to go to the bathroom. Finally, I noticed when I went to wipe his urine off the toilet seat, it was sticky. On March 5th, he was rushed to the emergency room; he was in Diabetic Ketoacidosis and when we arrived in the ER, his blood glucose was 900+. Patient is now a insulin dependent Type One Diabetic - with NO family history of Type one Diabetes.
Patient was under the age of 17 years old at the time of vaccination. Moderna Vaccine Dose 1 was administered to patient; however this was an error because Moderna vaccinations are only given to patients above the age of 18.
MMR + Varicella vaccine administered at 1000 a.m. and had seizure 60 seconds later. Child admitted to hospital and had seizure approximately 1600. Child transferred to another hospital.  10/05/2007 MR received for DOS 9/27-29/2007 for DX of Acute seizure after receiving MMR vaccination.  Immediately after receiving MMRV child cried and then eyes rolled back and jerking was noted in his arms. Episode lasted several minutes.  Transfered by EMS to local ER and admitted for observation.  That pm had another episode of seizure like activity with eyes rolling back and stiffness, lasting 30-40 sec. Sleepy post-ictal.  Transfered to current facility where another seizure occured similar to the first with additional staring episode noted.
Black and blue for about 3 weeks, loss of strength, unable to pick arm up above head without assist. Unable to sleep on right side due to pressure.
tested positive for the Covid 19; tested positive for the Covid 19; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect from a contactable consumer.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 18Dec2020 as the first single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient tested positive for the COVID 19 on 27Dec2020.  The patient underwent lab tests and procedures which included a test for Covid 19 virus, which was positive on 27Dec2020. The outcome of tested positive for the COVID 19 was unknown.   The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.; Sender's Comments: The information currently provided is too limited to make a meaningful medical assessment hence, the events are conservatively assessed as related to the suspect drug BNT162B2 until further information becomes available.
Racing heart, tingling sensation and ?heavy, full? feeling in the face; dizziness, confusion, difficulty concentrating and flushed face.  Racing heart began within the 15 min waiting period but I interpreted as anxiety.  Other symptoms began roughly 3 hrs post-vaccination.  Remedy was to leave work and go home, lay down in bed, and wait.  After a few hours symptoms mostly resolved, but face still feels strange (slight numbness and slight tingling).
Cellulitis of left arm. Treated w/ BACTRIM DS 800mg - 160mg tab.
Several weeks leading up to my doctors appointment on 3/11/2021, I was having increasing muscle pains, soreness and burning pain throughout my entire body especially my legs, back, buttocks and arms.  I also would get sharp pain in the lower part of my back.  I also noticed severe back pain when laying in bed and when I am adjusting my body to get comfortable.  By 3/11/2021 at my doctor's visit,  I presented with severe body pain, fatigue, and swollen left lymph nodes.  I did do blood work which indicate elevated creatine kinase protein enzymes 160   (which may indicate muscle damage to the heart) and I was instructed to discontinue my medication Atorvastatin. I did follow up with a rheumatologist and cardiologist. On 5/11/2021 I saw my cardiologist.   The cardiologist did an EKG with showed left ventricular hypertrophy. I was also sent for a stress test and ECHO which showed a 70% score. Around July 2021, I had persistent chest pains and decided to go to the ER and was admitted on 7/17/2021.    I did a lot of tests and I was discharged to follow up with cardiology.  I did follow up with my cardiologist and did an MRI on 8/18/2021 which showed acute idiopathic periocarditis and myocarditis.
Itchiness in the face; Rash in the left side of face; Rash is little bit warm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness in the face), FEELING HOT (Rash is little bit warm) and RASH (Rash in the left side of face) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, SIMVASTATIN, FINASTERIDE and TAMSULOSIN for an unknown indication.    On 02-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced PRURITUS (Itchiness in the face) and RASH (Rash in the left side of face). In February 2021, the patient experienced FEELING HOT (Rash is little bit warm). At the time of the report, PRURITUS (Itchiness in the face), FEELING HOT (Rash is little bit warm) and RASH (Rash in the left side of face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Client given vaccines below, informed client to stay seated while entering vaccines in computer. After 305 minutes client started leaning to the right towards the floor. Client's dad caught him before hitting the floor. Client was unresponsive breathing with heartbeat. Gurgling sounds started and clients hands started to draw up, small amount of movement noted for less than a minute, during this time, client was placed on a cushioned mat in the immunization room and cold wet towel was put on face. Ice to underarms and legs up on the chair. Client was out 1-2 minutes. After client was on floor 5-10 minutes, client set up and had coke and crackers, stated did not eat this AM, client aware of his surroundings. States has passed out before but just after immunizations. Client had a bowel movement while unresponsive, After sit up, client stood up with help to the chair and then dad accompanied client to the bathroom. Dad wanted to go to store for change of clothes. Informed someone now here could go get change of clothes so dad could stay here. Instead towel was given to client and client walked out with dad with towel around his waist. Informed dad, I would call and check on client tomorrow by phone. Encouraged dad to take client to pediatrician for workup. Physical and informed meds well check yearly with pediatrician.
Information has been received from a physician concerning a female with a history of failure to thrive and no drug reactions/allergies who in May 2007, was vaccinated with a dose of VAQTA. Concomitant therapy included a dose of PROQUAD (Oka/Merck upgrade process) (MSD) and a dose of DTaP (unspecified). After the patient went home, she developed generalized hives and swelling. She returned to the pediatrician's office where she received epinephrine, steroids, and BENADRYL. Subsequently, the patient recovered. There were no lab diagnostic studies performed. There was no product quality complaint. The events were considered to be other important medical events by the reporter. Additional information has been requested.
Face, neck, arms turned bright red; Face extremely swollen; Nausea; This is a spontaneous report from a contactable healthcare professional. A 56-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL0142), intramuscular (left arm) on 12Jan2021 10:00 at a single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included lamotrigine. The patient experienced Face, neck, arms turned bright red, Face extremely swollen, Nausea; all on 12Jan2021 10:45 AM. The outcome of the events was recovering.
Headache, Sedation, Myalgia, NauseaVomiting, shortness of breath, chills, and fatigue. pain at the  injection site. Narrative:  Other Relevant History:
Presented with SOB, CP, Cough, fever, N/V, weakness, loss of appetite x7 days; Dx resp failure due to Covid PNA; CXR: clear; Chest CT with groundglass density concerning for atypical PNA; labs: D-dimer 2.19, CRP 8.62; Ferritin >33,511;  treated with the dexamethasone, maxipime, zinc, lovenox, singulair, . Not placed on Remedesevir due to renal insufficiency. During the hospital course, patient was able to be weaned off oxygen.  Currently patient is on room air.
5MAR93 very sleepy as of 2PM; napped, woke @ 4 & was nauseated; 6MAR93 AM h/a & red bumpy itchy rash, began in axilla & neck, spread later to abdo; also diarrhea; 7MAR93 all sx gone x/rash;
Left armpit lymph nodes very swollen and sore, like the size of half a tennis ball in armpit for over a week.  could not put my arm down at side due to discomfort and swelling.
Started with flu like symptoms  that worsened over 36 hours. Then began having pian,  nerve issues and muscle weakness in left side of body (shoulder, elbow, hand and leg.
Extreme tiredness  Nausea   Headache  Muscle and joint pain  Generally Unwell
One hour after Fluzone vaccine administered patient developed red, raised welts on forearm that lasted for one hour.
Soreness of the Arm for 1 day; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Jun-2021 and was forwarded to Moderna on 09-Jun-2021.    This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Soreness of the Arm for 1 day) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness of the Arm for 1 day). At the time of the report, PAIN IN EXTREMITY (Soreness of the Arm for 1 day) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No information about concomitant medication was provided.  No treatment information was provided.   This case was linked to MOD-2021-032991 (Patient Link).
patient fainted from seated position in recovery waiting room. she was attended by Dr. for supportive care. paramedics were summoned and transported patient to medical center for further treatment. Symptoms were not anaphylaxis; most likely vasovagel response.
Upon receiving the 1st COVID Vaccine, patient felt dizzy and fainted within 2 minutes for receiving vaccine. Patient also experience an episode of seizure lasting roughly 1-2 minutes. Patient's eyes were closed during this time. Patient after was extremely tired and became awake. 911 was called and paramedic did arrive. Patient was provided comfort for 15-20 minutes until paramedics arrived.
inappropriate injection site; pain; unable to walk proprerly; This case was reported by a nurse via sales rep and described the occurrence of leg pain in a female patient who received Men B NVS (Bexsero) for prophylaxis.   In July 2018, the patient received Bexsero .5 ml. In July 2018, unknown after receiving Bexsero, the patient experienced vaccine administered at inappropriate site. On an unknown date, the patient experienced leg pain and unable to walk. On an unknown date, the outcome of the leg pain and unable to walk were recovered/resolved and the outcome of the vaccine administered at inappropriate site was unknown.   It was unknown if the reporter considered the leg pain and unable to walk to be related to Bexsero.  Additional details were provided as follows: The reporter gave consent to follow up. The patient received a dose of Bexsero in the leg per her mother's request. The patient declined to receive the 2nd dose of Bexsero. The patient did not notify the clinic until 27th June 2019.
SIRVA (shoulder injury related to vaccine administration); During injection shoulder pain / after injection it hurt worse; limited mobility of shoulder; BEXSERO via intrarticular injection; This case was reported by a nurse via call center representative and described the occurrence of shoulder injury related to vaccine administration in a 17-year-old female patient who received Men B NVS (Bexsero) (batch number ABXB36AA, expiry date 31st July 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 10th December 2021, the patient received Bexsero (intraarticular) and Bexsero Pre-Filled Syringe Device. On 10th December 2021, immediately after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced shoulder injury related to vaccine administration, shoulder pain, mobility decreased and intramuscular formulation administered by other route. On an unknown date, the outcome of the shoulder injury related to vaccine administration and intramuscular formulation administered by other route were unknown and the outcome of the shoulder pain and mobility decreased were not recovered/not resolved.   It was unknown if the reporter considered the shoulder injury related to vaccine administration, shoulder pain and mobility decreased to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: This case was reported by the nurse practitioner. The patient received dose of Bexsero vaccine in an unknown arm via intrarticular injection, which led to intramuscular formulation administered by other route. The patient experienced shoulder pain during injection and after injection it hurt worse. In middle of night following administration, the patient experienced significant pain. She also experienced limited mobility of shoulder.  She woke up because it was hurting so bad. She went to emergency room where on 11th December 2021 they said it was SIRVA (shoulder injury related to vaccine administration).  The reporter stated that they saw the patient in the morning of 13th December 2021 (day of reporting) and she was still in pain with limited mobility of shoulder. It's gotten a little better but still present. The reporter consented to follow-up.
Received MMR #1 on 3/16/07 reported few hours after receiving shot had "difficulty breathing, facial and lips swelling. Did not go to emergency room - was afraid.' Per MD MMR titers done to check immunisations.
No additional adverse event reported, no further information provided; The patient was vaccinated with PROQUAD instead of M-M-R II; The patient was vaccinated with PROQUAD instead of M-M-R II which was concomitantly given with a dose of VARIVAX; Product confusion; This spontaneous report was received from a registered nurse referring to a 1-year-old patient of unknown gender. The patient's concurrent conditions, pertinent medical history, concomitant medications, drug reactions or allergies were not reported.   On 15-FEB-2022, the nurse had product confusion on measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) and patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 milliliter, once (Lot# U028179 and expiration date : 08-MAR-2023)  as prophylaxis instead of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (vaccine not administered)  (Lot# and expiration date, exact dose and frequency were not reported) as prophylaxis which was concomitantly given with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter, once (Lot# U024765 and expiration date : 10-AUG-2023)  as prophylaxis (product confusion) (wrong product administered) (accidental overdose). No additional adverse event reported, no further information provided.
Second of three shot series. First shot given 26 Nov 02 with virtually no effect. Second shot given on 10 Dec 02. Initial reaction was minimal with no noticable effects. Starting about 24 hours later, arm very sore to touch, and body joints ache. Feels like when you worked out too hard the day before and now body is sore all over, especially in the joints. 48 hours later much more sore all over than the day before. No other symptoms.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patient was vaccinated with doses of M-M-R II (route of administration, dose, lot number and expiration date were not reported), every year for the last 4 or 5 years. The patient mentioned that she was a travelling nurse and annual vaccination was a requirement for her job. No adverse symptoms were reported. Product quality complaint (PQC) was not involved. Additional information has been requested.
headaches; sore arm; muscle aches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP, Other HCP and Pharmacist) for a sponsored program. Other Case identifier(s): 20201114988(3).  A 67 year-old female patient received bnt162b2 (BNT162B2), administration date 26Feb2021 (Batch/Lot number: unknown) at the age of 67 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1), for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovered" (2021), described as "sore arm"; MYALGIA (non-serious) with onset 2021, outcome "recovered" (2021), described as "muscle aches"; HEADACHE (non-serious), outcome "unknown", described as "headaches".  Additional Information: The patient reported she had her second Covid vaccination on 26Feb2021 and experienced a sore arm and muscle aches after receiving the vaccination which have since resolved. She is unsure if headaches are related to Opsumit or the Covid vaccination.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient is in a locked memory care unit of a skilled nursing facility. We had two vaccinators from the pharmacy performing vaccines in this group of patients; a staff member was assisting us in identifying patients. Staff nurse instructed vaccinator to provide a vaccine to patient in the striped shirt, and pointed in the direction of a patient wearing a black/tan striped shirt.  Vaccinator introduced herself to the patient, using the patient's name, asked if she could provide a COVID vaccine to the patient in the left arm, she replied, "Yes".  Upon completing the vaccination and returning to staff nurse, nurse responded that was NOT patient, but different patient, who had already received a dose of the vaccine from another vaccinator. The intended patient was sitting in a blue striped shirt in the table in front of patient.
Headache, cough, chest burning, SOB, rapid heart rate, eyes swelling, eyes bloodshot, green drainage from eyes, GI upset, flushed.  No further treatment.
Patient given H1N1 vaccine, while waiting patient complained of eye lid swelling and increased tearing. EMS evaluated, began to c/o increased eye lid swelling, then began coughing. EMS administered 50 mg BENADRYL IM R arm. 12:40 transported.
Severe stomach cramps; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: El9262) via an unspecified route of administration in the right arm on 24Feb2021 at 11:00 (at the age of 70-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Feb2021 at 15:00, the patient experienced severe stomach cramps within 4 hours of injection and diarrhoea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe stomach cramps and diarrhoea was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
After 2nd moderna covid shot: Aches, Fatigue, nausea, headache, foggy head- this was for 24 hrs After above- 2days later- foggy head, headache, exhaustion and trouble breathing  2nd day at night- exhausted, and developed red rash ?covid arm?- itchy, red, swollen, painful  3rd day- today- covid arm more pronounced
Symptoms 12-14 hours after vaccination. Aches, pain at injection site, nausea, upset stomach.